Pretreatment with L-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice

Pretreatment with L-histidine produces a shift from methamphetamine-induced stereotypical biting to persistent locomotion in mice
复制标题

DOI:
10.1016/j.pbb.2009.10.009
复制
发表时间:
2010-01-01
影响因子:
3.6
通讯作者:
Takemura, Motohiko
Takemura, Motohiko
中科院分区:
心理学4区
文献类型:
--
作者:
Kitanaka, Junichi;Kitanaka, Nobue;Takemura, Motohiko

文献摘要

被引文献

相似文献

甲基苯丙胺(METH; 10 mg/kg,i. p.)对雄性ICR小鼠的诱导奇异行为,包括持续的运动和刻板行为,这些行为被分为四类:刻板的摇头,盘旋,嗅闻和咬。用L-组氨酸(750 mg/kg,i. p.)显著降低了由METH诱导的刻板的叮咬,并显著增加了持续的运动。同时给予吡拉明或酮替芬(脑穿透性组胺H(1)受体拮抗剂;各10 mg/kg,腹腔注射),但不通过给予非索非那定(一种不穿过血脑屏障的非镇静组胺H(1)受体拮抗剂; 20 mg/kg)、唑来替定(一种脑穿透性组胺H(2)受体拮抗剂:10 mg/kg)、硫代哌丁胺或氯苄丙酸(脑穿透性组胺H(3)受体拮抗剂;各10 mg/kg)。L-组氨酸处理可显著增加下丘脑组胺含量。这些数据表明,L-组氨酸通过中枢组胺H1受体改变METH的作用。(C)2009 Elsevier Inc. All rights reserved.
The administration of methamphetamine (METH; 10 mg/kg, i.p.) to male ICR mice induced bizarre behaviors including persistent locomotion and stereotypical behaviors, which were classified into four categories: stereotypical head-bobbing, circling, sniffing, and biting. Pretreatment with L-histidine (750 mg/kg, i.p.) significantly decreased the stereotypical biting induced by METH and significantly increased persistent locomotion. This effect of L-histidine on behavior was completely abolished by simultaneous administration of pyrilamine or ketotifen (brain-penetrating histamine H(1) receptor antagonists; 10 mg/kg each, i.p.), but not by the administration of fexofenadine (a non-sedating histamine H(1) receptor antagonist that does not cross the blood-brain barrier; 20 mg/kg), zolantidine (a brain-penetrating histamine H(2) receptor antagonist: 10 mg/kg), thioperamide, or clobenpropit (brain-penetrating histamine H(3) receptor antagonists; 10 mg/kg each). The histamine content of the hypothalamus was significantly increased by L-histidine treatment. These data suggest that L-histidine modifies the effects of METH through central histamine H, receptors. (C) 2009 Elsevier Inc. All rights reserved.